We recently announced a partnership with Innovo Research, a provider-sponsored, provider-led network of high-performing medical organizations focused on innovative clinical research strategies.
With Innovo, ARC will continue advancing clinical research in Central Texas. ARC first opened its clinical research department in 2016 and was a major study center for COVID-19 vaccines in 2020 and 2021.
The partnership with Innovo enables ARC to provide Central Texas with access to advanced medical treatment by integrating cutting-edge research methodologies into patient care.
Anas Daghestani, MD, ARC President & CEO, expressed enthusiasm about this collaboration, stating, "We believe that by combining our decades of expertise in patient care with the experience of Innovo Research in innovative and rigorous clinical research, we can continue to enhance ARC's healthcare model that truly prioritizes patient outcomes and community well-being."
Jeff James, CEO of Innovo Research, echoed that enthusiasm, "We are thrilled to welcome Austin Regional Clinic into the Innovo family. Their dedication to patient-centric and high-quality care aligns perfectly with our mission, and we are confident that together, we will advance these goals."
See more in the news release.